SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?


To: Flagrante Delictu who wrote (21566)5/29/1998 12:58:00 PM
From: Henry Niman  Respond to of 32384
 
Bernie, Actually, an anti-retinoid was identified by ALRT, but AGN is supposed to be developing the lead compound. It's initial uses are expected to be topical to counteract the side affects caused by Retin-A and Renova as well as Accutane. Not use about an oral version and its effect on triglycerides.